CLChiara Laura

Chiara Laura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chiara Laura has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lymphoid tissue chemokines limit priming duration to preserve CD8 + T cell functionality

    by Lukas M. Altenburger, Daniela Claudino Carvoeiro, Philippe Dehio, Jianwen Zhou, Chiara Laura, ÀLex Bofi i Cuadros, Mitali Katoch, Caroline Krüger, Juliana Barreto de Albuquerque, Petra Pfenninger, et al.

    The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.


  • Open Access

    Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion

    by Valeria Fumagalli, Micol Ravà, Davide Marotta, Pietro Di Lucia, Chiara Laura, Eleonora Sala, Marta Grillo, Elisa Bono, Leonardo Giustini, Chiara Perucchini, et al.

    The development of a tractable small animal model faithfully reproducing human coronavirus disease 2019 pathogenesis would arguably meet a pressing need in biomedical research. Thus far, most investigators have used transgenic mice expressing the human ACE2 in epithelial cells (K18-hACE2 transgenic mice) that are intranasally instilled with a liquid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suspension under deep anesthesia. Unfortunately, this experimental approach results in disproportionate high central nervous system infection leading to fatal encephalitis, which is rarely observed in humans and severely limits this model’s usefulness. Here, we describe the use of an inhalation tower system that allows exposure of unanesthetized mice to aerosolized virus under controlled conditions. Aerosol exposure of K18-hACE2 transgenic mice to SARS-CoV-2 resulted in robust viral replication in the respiratory tract, anosmia, and airway obstruction but did not lead to fatal viral neuroinvasion. When compared with intranasal inoculation, aerosol infection resulted in a more pronounced lung pathology including increased immune infiltration, fibrin deposition, and a transcriptional signature comparable to that observed in SARS-CoV-2–infected patients. This model may prove useful for studies of viral transmission, disease pathogenesis (including long-term consequences of SARS-CoV-2 infection), and therapeutic interventions.